APG Asset Management US’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-3,033
Closed -$821K – 154
2025
Q3
$821K Hold
3,033
– – 0.01% 136
2025
Q2
$777K Hold
3,033
– – 0.01% 141
2025
Q1
$674K Hold
3,033
– – 0.01% 144
2024
Q4
$694K Buy
+3,033
New +$730K 0.01% 141
2024
Q2
– Sell
-16,541
Closed -$3.13M – 181
2024
Q1
$3.13M Sell
16,541
-11,681
-41% -$2.14M 0.02% 165
2023
Q4
$4.85M Buy
+28,222
New +$4.34M 0.03% 134

Other funds holding RMD

APG Asset Management US's RMD Position: Q4 2025 in Review

APG Asset Management US sold out of ResMed (RMD) in Q4 2025, closing a stake of 3,033 shares — an estimated $821K sold.

APG Asset Management US first reported a position in RMD in Q4 2023 and held it in 6 quarters. The position peaked at $4.85M in Q4 2023. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • APG Asset Management US reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 3,033 ResMed shares in Q4 2025, an estimated $821K.
  • APG Asset Management US first reported a position in ResMed in Q4 2023 and held it in 6 quarters.
  • APG Asset Management US's ResMed position peaked at $4.85M in Q4 2023.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.